Protocol of the Italian Radical Cystectomy Registry
NCT04228198 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2020-01-14
Summary
Background: Bladder cancer is the ninth most common type of cancer worldwide. In the past, Radical Cystectomy via open surgery has been considered the gold-standard treatment for muscle invasive bladder cancer. However, in recent years there has been a progressive increase in the use of robot-assisted laparoscopic radical cystectomy surgery. The aim of the current project is to investigate the surgical, oncological, and functional outcomes of patients with bladder cancer who undergo radical cystectomy surgery comparing three different surgical techniques (robotic-assisted, laparoscopic, and open surgery). Pre-, peri- and post-operative factors will be examined, and participants will be followed for a period of up to 24 months to identify risks of mortality, oncological outcomes, hospital readmission, sexual performance, and continence.
Methods: The study is an observational, prospective, multicenter, cohort study to assess patients affected by bladder neoplasms undergoing radical cystectomy and urinary diversion. The Italian Radical Cystectomy Registry is an electronic registry to prospectively collect the data of patients undergoing Radical Cystectomy conducted with any technique (open, laparoscopic, robotic-assisted). Twenty-eight urology departments across Italy will provide data for the study, with recruitment phase between 1st January 2017-31st June 2020). Information is collected from the patients at the moment of surgical intervention and during follow-up (3, 6, 12, and 24 months after radical cystectomy surgery). Peri-operative variables include surgery time, type of urinary diversion, conversion to open surgery, bleeding, nerves sparing and lymphadenectomy. Follow-up data collection includes histological information (e.g., post-op staging, grading and tumor histology), short- and long-term outcomes (e.g., mortality, post-op complications, hospital readmission, sexual potency, continence etc).
Discussion: The current protocol aims to contribute additional data to the field concerning the short- and long-term outcomes of three different radical cystectomy surgical techniques for patients with bladder cancer, including open, laparoscopic, and robot-assisted. This is a comparative-effectiveness trial that takes into account a complex range of factors and decision making by both physicians and patients that affect their choice of surgical technique.
Conditions
Interventions
- PROCEDURE
-
Radical cystectomy
Procedure/Surgery: Radical cystectomy. Removal of urinary bladder with three different approaches: i) Robotic-assisted, ii) Laparoscopic, and iii) Open Surgery
Sponsors & Collaborators
-
University of Roma La Sapienza
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-01
- Primary Completion
- 2020-01-01
- Completion
- 2020-06-30
Countries
- Italy
Study Locations
More Related Trials
-
Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer
NCT01196403 ·Status: UNKNOWN ·Phase: PHASE2
-
Ileal Conduit Versus Cutaneous Ureterostomy After Radical Cystectomy
NCT04610385 ·Status: UNKNOWN
-
Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma
NCT07043790 ·Status: COMPLETED ·Phase: NA
-
Prognostic Effect of Whether Doing PLND During RC for High-risk NMIBC
NCT05123625 ·Status: RECRUITING ·Phase: NA
-
Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder
NCT02968732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial
NCT01157676 ·Status: COMPLETED ·Phase: NA
-
Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy
NCT02039310 ·Status: COMPLETED
-
Radical CystEctomy or RaDio-chEMotherapy as Preferred Treatment for invasivE blaDder Cancer
NCT07008833 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Loop Resection or Cold-cup Biopsy? A Study Comparing the Accuracy of Muscle Samples During Bladder Tumor Surgery
NCT06796413 ·Status: COMPLETED ·Phase: NA
-
Active Surveillance vs in Office Fulguration for Low Grade Bladder Cancer Tumors
NCT05148728 ·Status: UNKNOWN ·Phase: NA
-
Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy
NCT02345473 ·Status: COMPLETED
-
Pre-operative Immuno-Nutrition in Radical Cystectomy
NCT06355518 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Enhanced Recovery After Radical Cystectomy Study
NCT02328417 ·Status: COMPLETED
-
Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer
NCT01734798 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Multicentric Evaluation of a Bladder Preservation Strategy
NCT01093066 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
NCT07225127 ·Status: RECRUITING
-
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
NCT06986304 ·Status: RECRUITING
-
Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer
NCT02716896 ·Status: TERMINATED ·Phase: NA
-
Histopathological Findings in En-Bloc vs Conventional Transurethral Resection of Bladder Tumors.
NCT07259798 ·Status: COMPLETED ·Phase: NA
-
Intravesical Adjuvant Electromotive Mitomycin-C
NCT01920269 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer
NCT01776138 ·Status: COMPLETED
-
Microscopic-spectroscopic Examination for Urothelial Tissue Characterization
NCT04310813 ·Status: COMPLETED
-
Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) Project
NCT05357768 ·Status: RECRUITING
-
Information Needs and Supportive Rehabilitation Over Time in Patients Undergoing Cystectomy in Bladder Cancer
NCT07180121 ·Status: ENROLLING_BY_INVITATION
-
Adjuvant Intraarterial Chemotherapy Following Surgery to Treat Locally Advanced Bladder Cancer
NCT01627197 ·Status: COMPLETED ·Phase: PHASE3